# Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management

> **NCT05184491** · PHASE4 · UNKNOWN · sponsor: **National Liver Institute, Egypt** · enrollment: 500 (estimated)

## Conditions studied

- Helicobacter Pylori

## Interventions

- **DRUG:** Naïve patients - ACO therapy
- **DRUG:** Naïve patients - LNDL therapy
- **DRUG:** Naïve patients - MNDL therapy
- **DRUG:** Treatment-experienced patients- LNDL therapy
- **DRUG:** Treatment-experienced patients- MNDL therapy

## Key facts

- **NCT ID:** NCT05184491
- **Lead sponsor:** National Liver Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-15
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-03-15
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05184491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05184491, "Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05184491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*